Last Price$15.5(1.1%)
Market Cap$3,104.9M
48.3%
Peers median - 7.1%
(0.2%)
Peers median - 2.3%
7.8%
Peers median - 49.4%
(41.1%)
Peers median - 8.4%
Competing with ALHC
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$3,104.9M | 5.4 | $8.2 47.0% overvalued | 187.4% | $2,703.6M | ($6,648.0K) | 48.3% | (0.2%) | 33.7% | (41.1%) | 7.8% | |
$436.0B | 5.9 | $1,047.3 124.2% undervalued | (1.6%) | $398.3B | $20.7B | 8.4% | 5.2% | 21.9% | 28.1% | 1.5% | |
$90.7B | 6.7 | $1,001.8 153.3% undervalued | (20.5%) | $176.8B | $4,552.0M | 3.2% | 2.6% | 43.4% | 161.3% | 4.9% | |
$87.2B | 5.8 | $942.9 202.7% undervalued | (6.0%) | $245.3B | $8,957.0M | 25.7% | 3.7% | 48.9% | 4.9% | 77.5% | |
$82.3B | 5.1 | $208.2 220.8% undervalued | (9.3%) | $372.8B | $6,326.0M | 4.2% | 1.7% | 13.8% | 3.7% | 109.5% | |
$31.5B | 6.1 | $797.8 205.0% undervalued | (23.7%) | $117.8B | $2,391.0M | 10.7% | 2.0% | 91.9% | 58.6% | 71.3% | |
$29.1B | 5.4 | $1,406.9 2,301.3% undervalued | (25.2%) | $163.1B | ($490.0M) | 5.9% | (0.3%) | 13.1% | 12.0% | 69.9% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$3,703.3M | 6.1 | $23.7 57.0% undervalued | (1.7%) | $9,177.6M | $950.3M | 56.6% | 10.4% | 100.0% | (15.2%) | 29.5% | |
$1,871.6M | 5.2 | $2.0 45.3% overvalued | 330.8% | $1,370.6M | $128.3M | (32.4%) | 9.4% | 53.9% | 1.2% | 0.0% | |
$65.5M | 5.0 | $46.2 463.3% undervalued | (85.9%) | $1,616.6M | ($2,834.8M) | (71.1%) | (175.4%) | 7.8% | (63.3%) | (145.5%) |
Compare ALHC Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Alignment Healthcare, Inc.ALHC
1.0x
27.2%
(4.8%)
(8.1%)
Median Peer Set
0.4x
7.2%
(9.5%)
1.6%
Bright Health Group, Inc.BHG
N/A
(51.9%)
86.2%
(103.4%)
Cigna CorporationCI
0.5x
8.4%
(18.9%)
2.6%
Clover Health Investments, Corp.CLOV
1.2x
(41.5%)
(31.3%)
(10.5%)
Centene CorporationCNC
0.2x
5.9%
27.4%
2.0%
CVS Health CorporationCVS
0.4x
4.2%
(43.6%)
1.2%
Elevance Health Inc.ELV
0.5x
3.2%
(0.0%)
3.4%
Humana Inc.HUM
0.2x
10.7%
(50.1%)
1.0%
Molina Healthcare, Inc.MOH
0.4x
19.3%
9.2%
2.9%
Oscar Health, Inc.OSCR
0.2x
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
1.0x
8.9%
(35.7%)
3.6%
Compare ALHC Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Alignment Healthcare, Inc. (ALHC) revenue growth compare to peers and the industry?
Alignment Healthcare, Inc. (ALHC) revenue growth is 48.3%, compared to the peers' median of 7.1%.
2. How does Alignment Healthcare, Inc. (ALHC) Free Cash Flow (FCF) margin compare to peers and the industry?
Alignment Healthcare, Inc. (ALHC) FCF margin is (0.2%), compared to the peers' median of 2.3%.
3. How does Alignment Healthcare, Inc. (ALHC) Total Debt to Equity ratio compare to peers and the industry?
Alignment Healthcare, Inc. (ALHC) Total Debt to Equity ratio is 7.8%, compared to the peers' median of 49.4%.
4. How does Alignment Healthcare, Inc. (ALHC) ROIC (Return on Invested Capital) compare to peers and the industry?
Alignment Healthcare, Inc. (ALHC) ROIC is (41.1%), compared to the peers' median of 8.4%.